Literature DB >> 24252251

miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.

Shixiang Guo1, Xuejun Xu1, Yichen Tang1, Chaobin Zhang1, Jian Li1, Yongsheng Ouyang1, Jingfang Ju2, Ping Bie3, Huaizhi Wang4.   

Abstract

PURPOSES: To investigate whether miR-15a inhibits cell proliferation and epithelial-mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC) via the down-regulation of B cell-specific moloney murine leukemia virus insertion site 1 (Bmi-1) expression. METHODS AND
RESULTS: miR-15a and Bmi-1 expressions in normal pancreatic tissue and PDAC tissue were measured. The relationship between miR-15a and Bmi-1 expression was analyzed. We found that miR-15a suppressed the expression of Bmi-1 and PDAC cell proliferation; E-cadherin expression was visibly up-regulated after silencing Bmi-1 by transfecting miR-15a into PDAC cell line.
CONCLUSION: miR-15a inhibits cell proliferation and EMT in PDAC via the down-regulation of Bmi-1 expression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bmi-1; EMT; Pancreatic ductal adenocarcinoma; Proliferation; miR-15a

Mesh:

Substances:

Year:  2013        PMID: 24252251     DOI: 10.1016/j.canlet.2013.10.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  Effects of aging on circadian patterns of gene expression in the human prefrontal cortex.

Authors:  Cho-Yi Chen; Ryan W Logan; Tianzhou Ma; David A Lewis; George C Tseng; Etienne Sibille; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

2.  Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer.

Authors:  Cheng Huang; Lihua Cao; Limin Qiu; Xiaoli Dai; Linwei Ma; Yingting Zhou; Huifen Li; Min Gao; Weiyong Li; Qing Zhang; Koulan Han; Hongzhen Lv
Journal:  Oncol Lett       Date:  2015-04-29       Impact factor: 2.967

4.  Effects of long term low- and high-dose sodium arsenite exposure in human transitional cells.

Authors:  Jianming He; Feng Wang; Fen Luo; Xuedan Chen; Xi Liang; Wenbin Jiang; Zhizhong Huang; Jiafan Lei; Fabo Shan; Xueqing Xu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.

Authors:  Christopher Alderman; Ayoub Sehlaoui; Zhaoyang Xiao; Yixin Yang
Journal:  Tumour Biol       Date:  2016-08-04

Review 6.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

7.  BMI-1, a promising therapeutic target for human cancer.

Authors:  Min-Cong Wang; Chun-Li Li; Jie Cui; Min Jiao; Tao Wu; L I Jing; Ke-Jun Nan
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

8.  Impact of BMI1 expression on the apoptotic effect of paclitaxel in colorectal cancer.

Authors:  Hsiang-Lin Tsai; Shin-Yu Pang; Hui-Ching Wang; Chi-Wen Luo; Qiao-Lin Li; Tzu-Yi Chen; Shao-Yu Fang; Jaw-Yuan Wang; Mei-Ren Pan
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

9.  MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.

Authors:  Ting Wang; Tengfei Chen; Hua Niu; Chang Li; Chun Xu; Yuanyuan Li; Rui Huang; Jun Zhao; Shuyan Wu
Journal:  Int J Mol Med       Date:  2015-05-21       Impact factor: 4.101

Review 10.  Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Geeta G Sharma; Yasuyuki Okada; Daniel Von Hoff; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-10-10       Impact factor: 17.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.